Abstract
This review presents the published data regarding the molecular determinants (enzymes, transporters, orphan nuclear receptors) of fluoroquinolones pharmacokinetics in humans. The clinical impact of these determinants (drug disposition, drug-drug interactions) is also discussed.
Keywords: Fluoroquinolone, ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin, pharmacokinetics, enzymes, drug transporters
Current Clinical Pharmacology
Title: Molecular Determinants of Fluoroquinolone Antibacterial Agents Pharmacokinetics
Volume: 4 Issue: 3
Author(s): Dominique Leveque and Francois Jehl
Affiliation:
Keywords: Fluoroquinolone, ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin, pharmacokinetics, enzymes, drug transporters
Abstract: This review presents the published data regarding the molecular determinants (enzymes, transporters, orphan nuclear receptors) of fluoroquinolones pharmacokinetics in humans. The clinical impact of these determinants (drug disposition, drug-drug interactions) is also discussed.
Export Options
About this article
Cite this article as:
Leveque Dominique and Jehl Francois, Molecular Determinants of Fluoroquinolone Antibacterial Agents Pharmacokinetics, Current Clinical Pharmacology 2009; 4 (3) . https://dx.doi.org/10.2174/157488409789375348
DOI https://dx.doi.org/10.2174/157488409789375348 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Virgin Olive Oil and Hypertension
Current Vascular Pharmacology Descending Necrotizing Mediastinitis: Current Strategies for Diagnosis and Treatment
Current Respiratory Medicine Reviews Safety Considerations of the Use of Second Generation Antipsychotics in the Treatment of Major Depression: Extrapyramidal and Metabolic Side Effects
Current Drug Safety Potential Role of Hydrogen Sulfide in the Pathogenesis of Vascular Dysfunction in Septic Shock
Current Vascular Pharmacology Diet and Heart Health: Moderate Wine Drinking Strengthens the Cardioprotective Effects of Fish Consumption
Current Pharmaceutical Biotechnology New Drugs for Epidural Analgesia
Current Drug Targets Acute Severe Arterial Hypertension: Therapeutic Options
Current Drug Targets Novel Immunotherapies for Hematological Malignancies
Current Molecular Pharmacology The Diagnosis of Drug-Induced Liver Disease
Current Clinical Pharmacology Oleanolic Acid and Related Triterpenoids from Olives on Vascular Function: Molecular Mechanisms and Therapeutic Perspectives
Current Medicinal Chemistry Biological Properties of Citrus Flavonoids Pertaining to Cancer and Inflammation
Current Medicinal Chemistry Rho Kinase Inhibitors and Novel Ocular Drug Delivery Systems- A Revolutionary Step Towards the Treatment of Glaucoma
Current Drug Delivery Is Combined Angiotensin-converting Enzyme Inhibition and Angiotensin Receptor Blockade Associated with Increased Risk of Cardiovascular Death in Hemodialysis Patients?
Current Hypertension Reviews Anesthetic-induced Myocardial Conditioning: Molecular Fundamentals and Scope
Current Medicinal Chemistry Nose to Brain Delivery of Nanoformulations for Neurotherapeutics in Parkinson’s Disease: Defining the Preclinical, Clinical and Toxicity Issues
Current Drug Delivery Omega-3 and Renal Function in Older Adults
Current Pharmaceutical Design An Insight into the Therapeutic Potential of Major Coffee Components
Current Drug Metabolism Do RAS Inhibitors Protect the Brain from Cerebral Ischemic Injury?
Current Hypertension Reviews Purine Ionotropic (P2X) Receptors
Current Pharmaceutical Design Activated Carbon/MoO<sub>3</sub>: Efficient Catalyst for Green Synthesis of Chromeno[<i>d</i>]pyrimidinediones and Xanthenones
Combinatorial Chemistry & High Throughput Screening